Renaissance Technologies LLC Purchases Shares of 300,300 Agilent Technologies, Inc. $A

Renaissance Technologies LLC purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 300,300 shares of the medical research company’s stock, valued at approximately $34,228,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Gabelli Funds LLC lifted its position in Agilent Technologies by 34.7% in the 1st quarter. Gabelli Funds LLC now owns 7,854 shares of the medical research company’s stock worth $895,000 after buying an additional 2,024 shares during the last quarter. Morningstar Investment Management LLC raised its stake in shares of Agilent Technologies by 27.1% during the first quarter. Morningstar Investment Management LLC now owns 20,965 shares of the medical research company’s stock worth $2,390,000 after acquiring an additional 4,475 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of Agilent Technologies by 56.6% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,439,782 shares of the medical research company’s stock worth $164,106,000 after acquiring an additional 520,399 shares in the last quarter. Bank of Nova Scotia lifted its holdings in shares of Agilent Technologies by 71.7% in the 1st quarter. Bank of Nova Scotia now owns 129,240 shares of the medical research company’s stock worth $14,731,000 after acquiring an additional 53,965 shares during the last quarter. Finally, Sei Investments Co. boosted its stake in shares of Agilent Technologies by 0.6% in the 1st quarter. Sei Investments Co. now owns 103,725 shares of the medical research company’s stock valued at $11,823,000 after purchasing an additional 594 shares in the last quarter.

Agilent Technologies Stock Up 1.9%

Shares of Agilent Technologies stock opened at $140.57 on Wednesday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.27. The stock has a market capitalization of $39.70 billion, a price-to-earnings ratio of 28.23, a P/E/G ratio of 2.45 and a beta of 1.25. The company’s 50 day moving average price is $130.88 and its 200-day moving average price is $125.31.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm earned $1.31 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is 20.48%.

Analysts Set New Price Targets

Several equities analysts recently commented on A shares. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Wall Street Zen downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday. Robert W. Baird upped their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Barclays raised their price objective on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Finally, Royal Bank Of Canada initiated coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.